Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacgen Life Science Corporation
Vancouver, British Columbia, Canadapacgenlife.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Pacgen’s main asset, the antimicrobial peptide P113/PAC–113 for oral candidiasis and other mucosal infections, completed Phase IIb clinical trials. The company has shifted to commercializing OTC products containing this peptide in Asia via sublicense to General Biologicals Corp. Its pipeline also included PAC-G31P for inflammatory diseases but no recent clinical updates are available. The diagnostics division distributes in-vitro diagnostic products from GBC in North America and China
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Peptides (e.g., antimicrobial peptide P113/PAC-113, PAC-G31P)
- Industry
- Biotech
02
Partnerships
– Sublicense agreement with General Biologicals Corp. for Asian markets.– Distribution partnership with GBC for diagnostics portfolio in North America & China.
Beyond the preview
Go deeper on Pacgen Life Science Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pacgen Life Science Corporation.